Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group-Reference-Cited by-同舟云学术

Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group

Published:2015-11-27 Issue:2 Volume:95 Page:263-269
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Giebel Sebastian,Sadus-Wojciechowska Maria,Halaburda Kazimierz,Drozd-Sokolowska Joanna,Wierzbowska Agnieszka,Najda Jacek,Mendrek Wlodzimierz,Sobczyk-Kruszelnicka Malgorzata,Nowicki Mateusz,Holowiecki Jerzy,Czerw Tomasz

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2557-y.pdf

Reference19 articles.

1. Olivieri A, Brunori M, Capelli D, Montanari M, Massidda D, Gini G et al (2004) Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. Eur J Haematol 72:10–17

2. Smardova L, Engert A, Haverkamp H, Raemakers J, Baars J, Pfistner B et al (2005) Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin’s disease. Leuk Lymphoma 46:1017–1022

3. Mohty M, Hübel K, Kröger N, Aljurf M, Apperley J, Basak GW et al (2014) Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 49:865–872

4. Josting A, Rudolph C, Reiser M, Mapara M, Sieber M, Kirchner HH et al (2002) Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease. Ann Oncol 13:1628–1635

5. Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, Trneny M et al (2012) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28:4184–4190

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group;Cancers;2024-07-19

2. Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma;Frontiers in Immunology;2024-07-18

3. Evaluation of efficacy and safety in the use of cytarabine for mobilization of hematopoietic stem cells in a reference hospital in northeastern Brazil;Hematology, Transfusion and Cell Therapy;2023-10

4. Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization;Biology;2021-07-15

5. Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group;Journal of Clinical Apheresis;2021-02-16